RxDoctor Payments Data

Anita Kohli-Pamnani

Allergy & Immunology · Orange, CTNPI 1598721391

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,480 of the $12,266 with a category attached, or 69.1%. Pfizer accounts for 74.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $6,587 and has fallen 99.2% since, to $50 in 2023.

$12,266in general payments, 2019–2025

Across 236 payments — averaging $51.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$9K
  • GSK$625
  • AstraZeneca$374
  • Genentech USA, Inc.$282
  • Regeneron Healthcare Solutions, Inc.$281
  • CSL Behring$260
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$8,48069%
  • Travel & lodging$991%
  • Food & beverage$3,66730%
  • Education$210%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,266 in reported general payments places this provider in the 85th percentile of 54 allergy & immunology providers in Connecticut.

See all allergy & immunology providers in Connecticut

Other allergy & immunology in Orange

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →